AOD-9604.
Growth-hormone fragment that targets fat metabolism without affecting blood sugar.
What AOD-9604 does.
Clinical effects most commonly reported. Individual response varies — your physician sets the appropriate cycle and dose.
- Stimulates lipolysis (fat breakdown) and inhibits lipogenesis
- Derived from the fat-reducing region of growth hormone
- Does not impact blood glucose or IGF-1 levels
- Subcutaneous injection
AOD-9604 is a modified fragment of growth hormone — the last 16 amino acids of the molecule, the region tied to fat metabolism — studied for body-composition support without the systemic effects of full HGH.
Get AOD-9604.
Start intake to purchase, or send a question first.
Prescription products require a consultation with a licensed clinician. Compounded medications are not FDA-approved. Results may vary. Discuss indications, risks, and eligibility with a licensed clinician. Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies.